<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Physicians’ Equity in Company Marketing Cosmetic Drug Faces Ethical Questions

Default sub title

minute read

by Inside Sources | February 10, 2020
placeholder

Medical ethicists are raising questions about a new aesthetic neurotoxin that is being prescribed by the same doctors who invested in its launch — a product that is now being sold without the standard consumer protection oversight.

Topics: Press Coverage